752232
Last Update Posted: 2016-01-01
Recruiting has ended
All Genders accepted | 50 Years-85 Years |
40 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Study Evaluating ACC-001 in Japanese Patients With Mild To Moderate Alzheimer's Disease
The study is to evaluate the safety, tolerability and whether there is an immune system response to multiple doses of ACC-001 with or without the use of a substance that may increase the response to the drug.
Eligibility
Relevant conditions:
Alzheimer Disease
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov